Team

The Atelerix Life Sciences Team is experienced in small molecule bio-technology, and has the drive to bring new drugs to market

Founders

David Kalergis, MBA/JD
Founder & CEO

  • Founder & former Chairman/CEO of Diffusion Pharmaceuticals Inc., a publicly-traded biotech firm in late-stage clinical trials (NASDAQ: DFFN)
  • Raised $150+ million from equity markets and high net worth investors
  • Previously Director of UVA Gateway, strengthening ties between industry and academia in the life sciences area
  • Previously on Board of Directors and General Counsel at Pharmaceutical Research Associates Health (NASDAQ: PRAH)
  • Co-founder and previous Director of Virginia National Bank (NASDAQ: VABK)

James Bates, MD/PhD

Chief Medical Officer

  • Co-Inventor of the novel platform technology
  • Former practicing anesthesiologist and Assoc. Prof., University of Iowa
  • Author of dozens of published papers in related areas
  • BA, Molecular Biology, University of California-Santa Barbara
  • MA, Biochemistry/Molecular Biology, University of California-Santa Barbara
  • PhD, Biochemistry/Molecular Biology, University of California-Santa Barbara
  • MD, Medicine, University of Miami School of Medicine

SCIENTIFIC ADVISORY BOARD

Benjamin Gaston, MD/PhD

Co-Inventor; Professor of Pediatrics and Vice Chair for Translational Research
Herman B Wells Center, Indiana University School of Medicine

Stephen Lewis, PhD

Co-Inventor, Professor, Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, Case Western Reserve University School of Medicine

James Bates, MD/PhD

Co-Inventor; Practicing anesthesiologist and Assoc. Professor of Anesthesiology, University of Iowa PhD, Biochemistry/Molecular Biology, University of California-Santa Barbara

Atelerix Chief Medical Officer